Conference on Downstream Oil & Gas

Conference on Downstream Oil & Gas To be held on 27 September 2013 at India Habitat Centre, New Delhi

 Conference Description

 As you must be aware, the Indian Petro Group is India’s leading news, information and market intelligence provider in the Indian oil & gas, power, fertilizer and petrochemical sectors through its websites indianpetro.com, indianfertilizer.com, energylineindia.com, indianpetrochem.com and IndianPetrochem.com. It delivers accurate, exclusive and independent sector specific information through its portals. As an extension of our work in these knowledge intensive sectors and in order to bring in more value to our clients, we have begun an Outreach Program aimed at direct one-on-one interface with various stakeholders in the sectors.

 The Downstream Oil & Gas Sector in India is under throes of a massive expansion, IndianOil refineries have an ambitious growth plan with an outlay of about Rs. 55,000 crore for capacity augmentation, de-bottlenecking, bottom upgradation and quality upgradation. Major projects under implementation include a 15 MMTPA grassroots refinery at Paradip, Orissa, Naphtha Cracker and Polymer Complex at Panipat, Panipat Refinery expansion from 12 MMTPA to 15 MMTPA, among others.
 Reasons and Benefits to Attend:

 We understand that you already have a robust business development plan underway and are hard pressed for time. However having a focussed audience involving individuals who have had many decades of experience in downstream industry can amplify your efforts and give you a head start in your company’s growth and expansion.

 A unique networking opportunity with the senior executives of Procurement and Materials Management in the Refinery and Pipelines Division of IOCL.
 Hearing their development plans for the forthcoming years.
 Getting an insight into dynamics of downstream sector in India
 Future planning for the upcoming projects and tenders from IOCL
 Unique opportunity to exhibit your products and services.
 Tracking recent developments in the downstream sector and how they affect you.
 Noting and discussing the issues and concerns through open discussion panels

 Who Should Attend:

 Equipment manufacturers, Investment Banks, Foreign Companies looking for Investment Opportunities, Consulting Companies. Banks & Legal firms, Policy & Decision Makers, Overseas Technology Provider, Service providers, Consulting Companies, Investment Banks, Researchers, Government & Regulation Bodies, Logistics Companies
 
 For more information kindly visit : http://www.companyprofilesandconferences.com/seminars-conferences/Energy-Resources-c3/Conference-on-Downstream-Oil-Gas.html                               

 Or

 Contact us at :

 Company Profiles And Conferences
 Phone: +919223375060 / 919223767111
 Fax: +91 22 27810778
 Email : info@companyprofilesandconferences.com
 Website : www.companyprofilesandconferences.com/

2nd Annual Mobile Apps 2013

2nd Annual Mobile Apps 2013 To be held on 30th August 2013 at Matthan Hotel, Bangalore, India

 The global mobile industry is witnessing volatile growth for last couple of years. Advancement of mobile technology, improved infrastructure and Smartphone revolution have allowed people to perform much more with their mobile phones than ever before. This has resulted in an exponential demand and growth of mobile applications.

 The mobile app market is thriving to great heights. More than hundreds of handsets are capable of installing and running apps and a swerve of big-name app stores are striving to compete. It is expected that the market for mobile applications will be "as big as the internet", peaking at 10 million apps in 2020.

 Presently India having over 800+ million mobile connections and 50-150m mobile internet users it is evident mobile apps are becoming very popular. By 2015 India is expected to have 237 million mobile internet “activated” connections. Entrepreneurs are focusing a lot on mobile apps which are internet rather than SMS based. Mobile App Stats in India - 100 million apps being downloaded in India every month. India’s app developer base is estimated at 250,000.

 With world’s foremost brands recognizing the need of their presence in at least one of the top applications stores and the average mobile application per brand rising over 25 (for top 100 brands, 250 in case of media companies globally); the mobile applications market has took new role in defining the marketing strategy of businesses. This has opened up new horizons for already booming mobile applications market and provides faster acceleration for the market. Though these global brands do not look to make money directly with apps; however, the apps are adding up their brand equity. The surge in number of app stores and availability of multi-platform apps has also reshaping the future of the market. The excitement around mobile applications is going to have a major impact on our economy, and our way of life.

 Key Speakers:-

 Ochintya Sharma, Vice President, Samsung India
 Raghavan Subramanian, Associate Vice President, Infosys Labs
 Anand Subbaraman, Senior Director, Product Strategy, Oracle
 Pragati Ogal Rai, Mobile Technology Evangelist, PayPal (North America)
 Vineet Durani, Director - Windows Phone Business Group, Microsoft
 Vikram Srinivasan, Director, Alcatel-Lucent Bell Labs
 Praful Bhoyar, Portfolio Director, Dell
 Udayan Banerjee, VP, NIIT Technologies
 Sudeendra Koushik, Practice Director, HCL Technologies
 Jeffrey Rufus, Head - Nokia App Store & Windows Marketplaces, Nokia
 Uttam Kumar, Head – New Technologies Innovation & Incubation – IT, Aircel
 Viswanath Poosala, Head of Bells Labs – India, Alcatel-Lucent
 Sridhar T. Pai, CEO, Tonse Telecom
 Prakash Sayini, Founder and Managing Director, MobiDex360 Solutions

 For more information kindly visit : http://www.companyprofilesandconferences.com/seminars-conferences/Mobile-Telecoms-c14/2nd-Annual-Mobile-Apps-2013.html                              

 Or

 Contact us at :

 Company Profiles And Conferences
 Phone: +919223375060 / 919223767111
 Fax: +91 22 27810778
 Email : info@companyprofilesandconferences.com
 Website : www.companyprofilesandconferences.com/
 

2nd Annual Pharma Anti-Counterfeiting Congregation 2013

2nd Annual Pharma Anti-Counterfeiting Congregation 2013 To be held on 8th and 9th october 2013 at Hilton Hotel, London, UK

CONFERENCE INTRODUCTION:-

Counterfeit Pharmaceuticals do not only provoke immense economic damage to pharmaceutical companies but are a great risk to the public. The increasing threat calls for immediate action against counterfeit medicines. Steps must be taken by governmental and international authorities as well as by every single affected pharmaceutical company. Counterfeit APIs and medicines pose a growing threat to patients worldwide, with increasing numbers in Europe and the USA. Customs all over the world find more and more illegally produced drugs. Moreover, drugs are increasingly sold via the Internet making it much easier to put counterfeits into circulation.

Counterfeiting of drugs and medical devices cost the pharmaceutical and medical device industry billions of dollars annually in lost revenues. This loss is amplified by the serious threats fake drugs pose to the health and safety of consumers. Directing your organization toward an successful brand protection system can be a daunting task given the sophistication of counterfeiters and the difficulty in tracking and prosecuting perpetrators. This in-depth workshop will teach you how to ensure you have a solid counterfeit program and help you to gain a better understanding of how to develop an efficient brand protection program. It is estimated that counterfeiting is a $600 billion a year problem. In fact, it's a problem that has grown over 10,000% in the past two decades, in part fuelled by CONSUMER DEMAND. The real truth is people who purchase counterfeit merchandise risk funding nefarious activities, contributing to unemployment, creating budget deficits and compromising the future of this country in the global economy.

WHY SHOULD YOU ATTEND:-

“2nd Annual Pharma Anti-Counterfeiting Congregation 2013 - Competences to Combat Counterfeits”

Get more from the event, with a broader scope bringing the whole communications value chain together. Enjoy and make the best out of our dedicated networking drinks time, meet the leading companies showcasing the products of tomorrow in the co-located exhibition. Expand your knowledge of the latest business models and strategies in the high-level conference.

KEY THEMES DISCUSSED AT THIS CONFERENCE:-

• Anti-Counterfeiting and Product Security in EU and USA: government policies & strategies
• Identifying current developments in counterfeits & ways to overcome threats
• Discovering successful business models - Opportunities & Challenges
• Identify main challenges and methods to improve global security
• International partnerships and EU & U.S. regulations to combat counterfeit medicines
• Practical Tips - Strategies for securing the supply chains of the 21st century - authentication, digital serialization, track and trace technologies and government enforcement And Many more...
Key Speakers Include:-
Wendy Greenall, EMEA Counterfeit Medicines Laboratory Manager, Pfizer
Steven Gore, AIDC Programme Lead, NHS
Tomazs Dzitko, CEO, Delfarma
Janice Kite, Traceability Director Healthcare, GS1 Global Office Healthcare
Phil Lewis, International Cooperation & Legal Affairs Department, Cooperation Programmes Service, University of Texas (USA)
Marv Shepherd, Director, Center for Pharmacoeconomic Studies, College of Pharmacy, University of Texas (USA)
Jose Henrique Vasi Werner, Partner, Dannemann Siemsen Advogados (Brazil)
Christoph Krahenbuhl, Managing Director, 3C Integrity
Prashant Yadav, Director of Healthcare Research, William Davidson Institute (Michigan, USA)
Mark Davison, CEO, Blue Sphere Health, Acting Chief Business Officer,PharmaSecure
Alex Hall, CEO, QPQuandary (Former Quality Unit Manager,  Roch

For more information kindly visit : http://www.companyprofilesandconferences.com/seminars-conferences/Pharmaceuticals-Healthcare-c13/2nd-Annual-Pharma-Anti-Counterfeiting-Congregation-2013.html                              

Or

Contact us at :

Company Profiles And Conferences
Phone: +919223375060 / 919223767111
Fax: +91 22 27810778
Email : info@companyprofilesandconferences.com
Website : www.companyprofilesandconferences.com/

Pharmaceutical Nanotechnology Congregation 2013

CompanyProfileandconferences.com promote a new conference "Pharmaceutical Nanotechnology Congregation 2013" from which you can Learn from the experts on the technical, quality, and regulatory considerations of nanotechnology.

 Pharmaceutical Nanotechnology Congregation 2013 To be held on 15th-16th October 2013 at Hilton Hotel, London, UK

 Nanotechnology has supported breakthrough innovation across many industries especially Pharmaceutical. Nanotechnology brings revolutionary changes in the field of life sciences including drug delivery, diagnostics, nutraceuticals and production of biomaterials. Pharmaceutical industry is facing unique pressure in bringing out their products to the market quicker and with a higher probability of success. Nanotechnology presents a possibility for all pharmaceutical companies to improve upon existing safe therapies and enjoy patent protection or significant increase the bioavailability of new molecular entities in development. Understanding the technical and regulatory hurdles necessary to safely and effectively leverage nanotechnology is the first step to realizing the potential benefits of this approach. Moreover, many pharmaceutical companies have begun exploiting nanotechnology in improving drug delivery and targeting. In oncology, for instance, nanomedicines are being tested for their ability to reach cell targets that have otherwise eluded more conventional medicines.

 Nanomaterials have been increasingly recognized as a promising component of the future of biotechnology and biomedicine. The global market for nanomedicine was valued at $72.8 billion in 2011 and is projected to grow at a robust compound annual growth rate (CAGR) of 12.5%, reaching $130.9 billion by 2016. The overall anticancer nanomedicine market reached $28 billion in 2011, up from $16.4 billion in 2006, a 71% increase. It is expected to reach $46.7 billion by 2016, a CAGR of 10.8% between 2011 and 2016.

 Yet, the nature of this scientific advancement remains surrounded by “unknown unknowns.” And there is a need for companies—in the pharma sector and beyond—to be proactive in the management and communication of this technology. So for pharmaceutical companies, the question is not, “Is nano a stakeholder concern?” but rather, “What do we need to learn, and then what do we need to show our stakeholders to gain their trust?”

 Due to the variety of potential applications (including industrial and military), governments have invested billions of dollars in nanotechnology research. Through its National Nanotechnology Initiative, the USA has invested 3.7 billion dollars. The European Union has invested 1.2 billion and Japan 750 million dollars.

 Key Speakers:-

 Marianne Ashford, Drug Delivery – Principal Scientist, AstraZeneca
 Sumit Munjal, EU Medical Advisor & Pharmacovigilance Director, Global Safety - Oncology Portfolio, Takeda
 Tom Kurzawinski, Consultant Pancreatic and Endocrine Surgeon, University College London Hospitals - NHS Foundation Trust, Royal Free Hospital
 Sanyogitta Puri, Senior Scientist - Medicines Evaluation, Pharmaceutical Development, AstraZeneca
 Milos Todorovic, Lead Analyst - Practice Leader, Lux Research (Boston, USA)
 Helen Townley, Senior Research Fellow - Dept. Engineering Science, Oxford University
 Brij Patel, CEO, RegExcelconsulting (Former Biological Assessor, MHRA)
 Ijeoma F. Uchegbu, Chair in Pharmaceutical Nanoscience, Department of Pharmaceutics, UCL School of Pharmacy
 Twan Lammers, Head of work groups - Department of experimental molecular imaging, University of Twente (Germany)
 Jeffrey H. Rosedale, Partner, Woodcock Washburn (Philadelphia)
 Peter Bogaert, Managing Partner, Covington & Burling (Belgium)

 For more information kindly visit : http://www.companyprofilesandconferences.com/seminars-conferences/Pharmaceuticals-Healthcare-c13/Pharmaceutical-Nanotechnology-Congregation-2013.html                             

 Or

 Contact us at :

 Company Profiles And Conferences
 Phone: +919223375060 / 919223767111
 Fax: +91 22 27810778
 Email : info@companyprofilesandconferences.com
 Website : www.companyprofilesandconferences.com/
 

Pre-Filled Syringes Congregation 2013

CompanyProfileandconferences.com promote a new conference which provides “Successful Strategies, Safety Inspection, Packaging, Regulatory Compliance & Commercialisation of Pre-Filled Syringes for the emerging market”

 Pre-Filled Syringes Congregation 2013 To be held on 25th-26th June 2013 at Hilton London Euston, London, UK

 The drug delivery and packaging industries are rapidly expanding, with pre-filled syringes alone predicted to exceed $4.0bn by 2015. Pre-filled syringes constitutes one of the fastest growing markets in the drug delivery and packaging sectors with total revenues in this market expected to reach $5.5bn in 20251. It continues to offer one of the highest growth potentials in the pharmaceutical industry with 20% CAGR over the past 5 years. This is driven by a marked rise in the success of biological drugs and vaccines market, which requires the drug to be injected directly into the bloodstream.

 This helps facilitate absorption compared to oral delivery, which results in the drug being degraded in the stomach or metabolized by the liver before it is circulated systemically. It's difficult to reproduce these benefits with other drug delivery systems so it is unlikely to be replaced anytime soon. With the prospect of easier administration, reduced risk of detrimental occurrences and cost-effectiveness, its no wonder Pre-filled syringes Market are fast becoming the drug delivery system of choice. The continued focus of the pharmaceutical industry on biologics will mean there will be continued demand for this delivery method into the future. Pre-Filled Syringes 2013 will look at key areas including device development and the design concept; secondary packaging and quality assurance; site design and regulation and will deliver vital advice on how to create strategies for future commercial success. Delivering an in-depth market overview, whilst delivering perceptive looks into regulatory considerations, formulations and sterilization

 KEY THEMES DISCUSSED AT THIS SUMMIT:-

 How should the industry approach the rapidly emerging and developing pre-filled syringes?
 How are policy makers shaping the contours of pre-filled syringes, and what implications they have for current biologic drug development and patent protection?
 Discover new developments in the technology used to make pre-filled syringes
 Commercial challenges and opportunities - strategies to develop pre-filled syringes
 Opportunities for outsourcing of pre-filled syringes, challenges faced and cost effectiveness
 Learn to implement best practices through recent successful strategies and business models – real time case studies
 Learning the latest novel technologies in filling, closing and secondary packaging
 Analysing all phases of facility design and understand the requirements of pre-filled syringes development lines
 Primary container developments - Glass Vs Plastic
 Risks in terms of filling techniques - volume, viscosity, foaming, trapped air in the syringe
 Ascertaining the volume and level of safety that will be required to prove patient safety and efficacy to facilitate approval
 Inspection technologies are available to ensure validity and quality of pre-filled syringes to ensure safety and regulatory compliance
 Understanding the current regulatory and commercialisation considerations for Pre-Filled Syringes 2013 in Europe and the US
 Be part of a major networking opportunity

 WHO SHOULD ATTEND:-

 Presidents, Chief Executives, Chief Scientific Officers, Chief Operating Officers, Senior Vice Presidents, Vice Presidents, Heads, Senior Directors, Directors, Clinicians, Principal Scientists, Principal Investigators, Managers, Project/Team Leaders:

 Parenteral drug delivery, Drug Delivery, Vaccines, Packaging, Devices, Labelling, Manufacturing, Sterilisation, Sterile process systems, Technical support, Pharmaceutical formulation, Product design, Research and development, Drug discovery and delivery, Drug product process development, Drug device process development, Drug device safety, Regulatory affairs, Quality assurance, Quality control, Supply chain and procurement, Business development, Strategic alliances,Clinical product resourcing, Contract management, Investment and venture capital

 For more information kindly visit : http://www.companyprofilesandconferences.com/seminars-conferences/Conference-c42/Pre-Filled-Syringes-Congregation-2013.html                            

 Or

 Contact us at :

 Company Profiles And Conferences
 Phone: +919223375060 / 919223767111
 Fax: +91 22 27810778
 Email : info@companyprofilesandconferences.com
 Website : www.companyprofilesandconferences.com/

7th Cloud Computing Summit 2013

7th Cloud Computing Summit 2013 To be held on 9th July 2013 at Taj Vivanta - MG Road, Bangalore, India

 Cloud Computing has become one of the hottest IT enterprise topics of recent times. It is fast becoming mainstream with large steps being made in a relatively short period of time. Cloud Computing has become a scalable services consumption and delivery platform in the field of Services Computing. The technical foundations of Cloud Computing include Service-Oriented Architecture (SOA) and Virtualizations of hardware and software. The goal of Cloud Computing is to share resources among the cloud service consumers, cloud partners, and cloud vendors in the cloud value chain. The resource sharing at various levels results in various cloud offerings such as infrastructure cloud (e.g. hardware, IT infrastructure management), software cloud (e.g. SaaS focusing on middleware as a service, or traditional CRM as a service), application cloud (e.g. Application as a Service, UML modelling tools as a service, social network as a service), and business cloud (e.g. business process as a service).

 According to IDC, within just a few years, cloud computing has reshaped the IT marketplace and the way that organizations acquire and use IT products and services, disrupting their strategies and forcing them to reevaluate all of their alternatives to the status quo. Now the use of cloud computing is accepted as mainstream, this disruption is creating new opportunities for suppliers and catalyzing major changes in traditional.

 7th Cloud Computing 2013 is the only event focused on how traditional enterprises can adopt cloud computing models, featuring panels of thought leaders, candid conversations with industry luminaries. The conference is a reality check to better understand enterprise cloud computing. Cloud computing is big news, promising unlimited capacity and pay-as-you-go economics, plus connections to an always-on world. Enterprises are excited about cloud computing but little of it is ready to use yet. Clouds present security risks, and many enterprise applications have to be completely rewritten to run on scalable clouds. Forward-thinking business leaders are using the cloud within their enterprise data centers to take advantage of the best practices that cloud computing has established, namely scalability, agility, automation, and resource sharing. Although the term 'cloud computing' is relatively new, the technologies that make it possible have been used for some time.

 For example, cloud computing is enabled by grid computing, virtualization, utility computing, hosting and software as a service (SaaS). Virtualization is driving a fundamental shift in how we think about data center environments. It is lowering capital and operational costs, enabling IT agility, underlying Green IT initiatives and fuelling the cloud. This conference helps us to be aware of this paradigm shift and discusses the benefits of virtualization.

 This Cloud Computing conference is the place to meet all the key decision makers from all of the Cloud service providers in one place. This conference will address the current state of the market, the business value of the cloud, deployment strategies and integration techniques,security and privacy issues and will take a look into what the future holds for Cloud Computing.

 It gives us immense pleasure in welcoming you to the 7th Cloud Computing 2013

 Key themes discussed at this Summit:

 • Identifying current trends of Cloud Computing environment and how can you take advantage of the global market – Opportunities and Challenges
 • The Changing role of IT with the Cloud
 • Discovering successful business models for cloud computing - Cloud Gaming and Cloud TV
 • Rise of big data in your organisation - Making better informed decisions for your organisation
 • Creating new value chain and eco-system of mobile cloud computing
 • Driving telcos role in cloudscape – Understanding landscape of mobile cloud Computing
 • Best practice - Virtualization strategy
 • Discover why Cloud Computing is perfect for SME’s - Key advantages of cloud hosting for SMEs
 • Infrastructure, Deployment, Integration & Monetizing the Cloud business
 • How to move your business to cloud computing - practical tips
 • Learn from the industry leaders and emerging players offering to Cloud and SaaS space
 • Avoiding potential pitfalls in Cloud Computing and to improve your clients relationships
 • Optimising Cloud Computing Operation effectiveness for successful ROI
 • Best Practices for Business Data Storage & Backups
 • Tangible benefits & risk of moving to the cloud –security/compliance/data risks
 • SaaS, PaaS, IaaS - Present & Future outlook
 • Cloud Concerns and the Future – Where are we heading with this cloud era?
 • Network in our combined exhibition and catering area
 • Evening networking reception for all attendees

 For more information kindly visit : http://www.companyprofilesandconferences.com/seminars-conferences/Technology-c29/7th-Cloud-Computing-Summit-2013.html                           

 Or

 Contact us at :

 Company Profiles And Conferences
 Phone: +919223375060 / 919223767111
 Fax: +91 22 27810778
 Email : info@companyprofilesandconferences.com
 Website : www.companyprofilesandconferences.com/

5th Annual EPC Contracting Conference Summit 2013

EPC- The Changing Scenario: It is a must attend event for senior finance decision makers, taxation, legal and commercial professionals from large domestic and multinational EPC / Infrastructure companies & owner companies in India. The purpose of the event is to network, discuss and debate key tax legal and other policy developments."

BACKGROUND

Sub-Group on Infrastructure for 12th Five year plan (2012-17) has estimated US$ 1 trillion (approx) investments requirement for infrastructure sector over the next five year to sustain and boost the current GDP. 5th Annual EPC Contracting Conference Summit 2013

As the government is getting aggressive on reforms, there are more to come. India is capable of high growth and that large infrastructure projects are one of the areas of focus. The negative perception of India caught in policy logjam is changing as political support is increasing credibility of government policies

Among other initiatives, in December 2012, Cabinet Committee on Investment (CCI) has been set up under chairmanship of Prime Minister and comprises members from various ministries to facilitate speedy implementation of large scale projects. CCI has started meeting and is expected to facilitate the project approvals, etc. Almost, all the large projects will involve Engineering, Procurement and Construction (EPC) contracting.

It may be noted that tax is one of the key aspect which needs due attention while contracting EPC projects. It is pertinent to note that, each EPC contract is unique in terms of size, scale, complexity, content of offshore services and supplies, location of performance, etc. Further, each EPC contract involves multiple taxes and levies.

For more information kindly visit :   5th Annual EPC Contracting Conference Summit 2013